Compare XL Axiata Tbk. (EXCL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
XL Axiata Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? XL Axiata Tbk. trades at Rp2,630 (market cap 49.14T, 6.84M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: XL Axiata Tbk. is far larger — about 470.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| EXCL | SCPI | |
|---|---|---|
Market Cap | 49.14T | 104.4B |
Volume | 6.84M | — |
Lot | 68.44K | — |
Turnover | 18.12B | — |
Average Price | 2,647.02 | — |
Value | 18.12B | — |
Indicative Equilibrium Price | 2,630 | — |
Indicative Equilibrium Volume | 2.22K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About XL Axiata Tbk.
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
